Retained Earnings - Diffusion Pharmaceuticals Inc (NASDAQ:CRVO) - Alpha Spread
D

Diffusion Pharmaceuticals Inc
NASDAQ:CRVO

Watchlist Manager
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Watchlist
Price: 17.47 USD 10.57% Market Closed
Market Cap: 144.2m USD
Have any thoughts about
Diffusion Pharmaceuticals Inc?
Write Note

Diffusion Pharmaceuticals Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Diffusion Pharmaceuticals Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
D
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Retained Earnings
-$54.4m
CAGR 3-Years
22%
CAGR 5-Years
9%
CAGR 10-Years
2%
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$3.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
$11.2B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$27.1B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-17%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
$7.6B
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$29.4B
CAGR 3-Years
25%
CAGR 5-Years
38%
CAGR 10-Years
84%

See Also

What is Diffusion Pharmaceuticals Inc's Retained Earnings?
Retained Earnings
-54.4m USD

Based on the financial report for Jun 30, 2024, Diffusion Pharmaceuticals Inc's Retained Earnings amounts to -54.4m USD.

What is Diffusion Pharmaceuticals Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
2%

Over the last year, the Retained Earnings growth was 64%. The average annual Retained Earnings growth rates for Diffusion Pharmaceuticals Inc have been 22% over the past three years , 9% over the past five years , and 2% over the past ten years .

Back to Top